1. Home
  2. PCVX vs GNRC Comparison

PCVX vs GNRC Comparison

Compare PCVX & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • GNRC
  • Stock Information
  • Founded
  • PCVX 2013
  • GNRC 1959
  • Country
  • PCVX United States
  • GNRC United States
  • Employees
  • PCVX N/A
  • GNRC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • GNRC Metal Fabrications
  • Sector
  • PCVX Health Care
  • GNRC Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • GNRC Nasdaq
  • Market Cap
  • PCVX 4.4B
  • GNRC 7.5B
  • IPO Year
  • PCVX 2020
  • GNRC 2010
  • Fundamental
  • Price
  • PCVX $33.27
  • GNRC $150.56
  • Analyst Decision
  • PCVX Strong Buy
  • GNRC Buy
  • Analyst Count
  • PCVX 10
  • GNRC 18
  • Target Price
  • PCVX $136.50
  • GNRC $170.72
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • GNRC 1.0M
  • Earning Date
  • PCVX 08-05-2025
  • GNRC 07-30-2025
  • Dividend Yield
  • PCVX N/A
  • GNRC N/A
  • EPS Growth
  • PCVX N/A
  • GNRC 58.27
  • EPS
  • PCVX N/A
  • GNRC 5.74
  • Revenue
  • PCVX N/A
  • GNRC $4,348,682,000.00
  • Revenue This Year
  • PCVX N/A
  • GNRC $5.47
  • Revenue Next Year
  • PCVX N/A
  • GNRC $6.75
  • P/E Ratio
  • PCVX N/A
  • GNRC $26.27
  • Revenue Growth
  • PCVX N/A
  • GNRC 8.07
  • 52 Week Low
  • PCVX $27.66
  • GNRC $99.50
  • 52 Week High
  • PCVX $121.06
  • GNRC $195.94
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 46.99
  • GNRC 78.91
  • Support Level
  • PCVX $32.00
  • GNRC $140.75
  • Resistance Level
  • PCVX $34.63
  • GNRC $143.70
  • Average True Range (ATR)
  • PCVX 1.31
  • GNRC 3.57
  • MACD
  • PCVX -0.08
  • GNRC 1.94
  • Stochastic Oscillator
  • PCVX 37.46
  • GNRC 98.37

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About GNRC Generac Holdlings Inc.

Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.

Share on Social Networks: